# US 2016/0251618 A1 · Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251618 A1
- Document ID: US20160251618A1
- Status: Published application
- Kind: A1
- Application number: 15/143,141
- Filed: 2016-04-29
- Published: 2016-09-01
- Earliest claimed: 2009-08-24
- Assignees: Wisconsin Alumni Research Foundation
- Applicants: Wisconsin Alumni Research Foundation
- Inventors: David Matthew Gamm; Jason Steven Meyer
- Web page: https://patentgrep.com/patent/US20160251618A1

## CPC

- C12N 5/0621: {Eye cells, e.g. cornea, iris pigmented cells (photoreceptors C12N5/062)}
- A61P 27/02: Ophthalmic agents
- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- C12N 5/0602: {Vertebrate cells}
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/16: Activin; Inhibin; Mullerian inhibiting substance
- C12N 2501/91: Heparin
- C12N 2506/02: from embryonic cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Methods for producing substantially pure cultures of human neural retinal progenitor cells, forebrain progenitor cells, and retinal pigment epithelial cells are disclosed. In addition, the successful differentiation of human embryonic stem cells and human induced pluripotent stem cells through the major developmental stages of human retinogenesis is disclosed.

## Claims

### Claim 1

A method for generating a cell culture comprising a population of cells wherein at least 90% of the cells in the population are human retinal pigment epithelium (RPE) cells, comprising culturing a population of floating retinal progenitor cell (RPC) neurospheres, wherein the RPC neurospheres have a vesicular morphology and include a hollow center and an outer ringlike laminar layer comprising human retinal progenitor cells oriented radially outwards relative to the neurosphere center, and wherein the outer ring-like laminar layer appears phase-bright and golden in color when observed using bright-field microscopy, identifying a plurality of pigmented neurospheres within the population, and isolating the plurality of pigmented neurospheres from the population into a composition to obtain a cell culture comprising RPE neurospheres comprising a population of cells wherein at least 90% of the cells in the population are RPE cells, wherein the RPE cells comprise the genetic background of a subject having a retinal degenerative disease.

### Claim 2 (depends on 1)

The method of claim 1, wherein the culturing is serum free.

### Claim 3 (depends on 2)

The method of claim 2, wherein the population of RPC neurospheres is cultured in the presence of Activin.
